J&J Keeps Expectations Conservative For OTC Manufacturing Remediation
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson expects the resumption of manufacturing the children's OTC drugs the firm's McNeil Consumer Healthcare business recalled this year may be as far off as April 2011